Annual CAPEX:
$374.00K-$7.00M(-94.92%)Summary
- As of today, TSHA annual capital expenditures is $374.00 thousand, with the most recent change of -$7.00 million (-94.92%) on December 31, 2024.
- During the last 3 years, TSHA annual CAPEX has fallen by -$21.18 million (-98.26%).
- TSHA annual CAPEX is now -98.50% below its all-time high of $24.87 million, reached on December 31, 2022.
Performance
TSHA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CAPEX:
$108.00K+$106.00K(+5300.00%)Summary
- As of today, TSHA quarterly capital expenditures is $108.00 thousand, with the most recent change of +$106.00 thousand (+5300.00%) on September 30, 2025.
- Over the past year, TSHA quarterly CAPEX has increased by +$73.00 thousand (+208.57%).
- TSHA quarterly CAPEX is now -99.05% below its all-time high of $11.43 million, reached on March 31, 2022.
Performance
TSHA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$490.00K+$73.00K(+17.51%)Summary
- As of today, TSHA TTM capital expenditures is $490.00 thousand, with the most recent change of +$73.00 thousand (+17.51%) on September 30, 2025.
- Over the past year, TSHA TTM CAPEX has increased by +$97.00 thousand (+24.68%).
- TSHA TTM CAPEX is now -98.49% below its all-time high of $32.45 million, reached on March 31, 2022.
Performance
TSHA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TSHA CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -94.9% | +208.6% | +24.7% |
| 3Y3 Years | -98.3% | -96.4% | -98.4% |
| 5Y5 Years | +100.0% | - | - |
TSHA CAPEX Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -98.5% | at low | -97.2% | +5300.0% | -98.4% | +29.6% |
| 5Y | 5-Year | -98.5% | >+9999.0% | -99.0% | +5300.0% | -98.5% | +29.6% |
| All-Time | All-Time | -98.5% | >+9999.0% | -99.0% | >+9999.0% | -98.5% | >+9999.0% |
TSHA CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $108.00K(+5300.0%) | $490.00K(+17.5%) |
| Jun 2025 | - | $2000.00(-99.5%) | $417.00K(-32.3%) |
| Mar 2025 | - | $378.00K(>+9900.0%) | $616.00K(+63.0%) |
| Dec 2024 | $374.00K(-94.9%) | $2000.00(-94.3%) | $378.00K(-3.8%) |
| Sep 2024 | - | $35.00K(-82.6%) | $393.00K(-89.8%) |
| Jun 2024 | - | $201.00K(+43.6%) | $3.86M(+4.1%) |
| Mar 2024 | - | $140.00K(+723.5%) | $3.71M(-50.4%) |
| Dec 2023 | $7.37M(-70.4%) | $17.00K(-99.5%) | $7.46M(-23.5%) |
| Sep 2023 | - | $3.50M(+7191.7%) | $9.76M(+5.2%) |
| Jun 2023 | - | $48.00K(-98.8%) | $9.28M(-46.5%) |
| Mar 2023 | - | $3.90M(+68.9%) | $17.34M(-30.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $24.87M(+15.4%) | $2.31M(-23.5%) | $24.87M(-20.0%) |
| Sep 2022 | - | $3.02M(-62.8%) | $31.08M(-3.1%) |
| Jun 2022 | - | $8.11M(-29.0%) | $32.06M(-1.2%) |
| Mar 2022 | - | $11.43M(+34.1%) | $32.45M(+50.5%) |
| Dec 2021 | $21.55M(+137.3%) | $8.52M(+112.9%) | $21.55M(+12.9%) |
| Sep 2021 | - | $4.00M(-52.9%) | $19.09M(+26.5%) |
| Jun 2021 | - | $8.50M(+1491.4%) | $15.08M(+129.1%) |
| Mar 2021 | - | $534.00K(-91.2%) | $6.58M(+8.8%) |
| Dec 2020 | $9.08M(>+9900.0%) | - | - |
| Dec 2020 | - | $6.05M(>+9900.0%) | $6.05M(>+9900.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $0.00 | - | - |
FAQ
- What is Taysha Gene Therapies, Inc. annual capital expenditures?
- What is the all-time high annual CAPEX for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. annual CAPEX year-on-year change?
- What is Taysha Gene Therapies, Inc. quarterly capital expenditures?
- What is the all-time high quarterly CAPEX for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. quarterly CAPEX year-on-year change?
- What is Taysha Gene Therapies, Inc. TTM capital expenditures?
- What is the all-time high TTM CAPEX for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. TTM CAPEX year-on-year change?
What is Taysha Gene Therapies, Inc. annual capital expenditures?
The current annual CAPEX of TSHA is $374.00K
What is the all-time high annual CAPEX for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high annual capital expenditures is $24.87M
What is Taysha Gene Therapies, Inc. annual CAPEX year-on-year change?
Over the past year, TSHA annual capital expenditures has changed by -$7.00M (-94.92%)
What is Taysha Gene Therapies, Inc. quarterly capital expenditures?
The current quarterly CAPEX of TSHA is $108.00K
What is the all-time high quarterly CAPEX for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high quarterly capital expenditures is $11.43M
What is Taysha Gene Therapies, Inc. quarterly CAPEX year-on-year change?
Over the past year, TSHA quarterly capital expenditures has changed by +$73.00K (+208.57%)
What is Taysha Gene Therapies, Inc. TTM capital expenditures?
The current TTM CAPEX of TSHA is $490.00K
What is the all-time high TTM CAPEX for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high TTM capital expenditures is $32.45M
What is Taysha Gene Therapies, Inc. TTM CAPEX year-on-year change?
Over the past year, TSHA TTM capital expenditures has changed by +$97.00K (+24.68%)